Health ❯ Public Health ❯ Infectious Diseases

COVID-19

Variants Vaccination Statistics Long COVID Symptoms Case Reporting Pandemic Response Epidemiology Testing Case Management

FDA Approves Xocova as First Oral Post-Exposure COVID-19 Prophylaxis

Clinical trial data show a 67% cut in symptomatic infections when the five-day pill course is started within 72 hours of exposure.

Brooklyn Rivera Dies in Nicaraguan State Custody

Brooklyn Rivera Dies in Nicaraguan State Custody

FDA Approves Xocova as First U.S. Post-Exposure COVID-19 Antiviral

HHS Defends Urologist Leading U.S. Hantavirus Response

Study Links COVID-19 Spread Between Spanish Apartments to Shared Bathroom Ventilation

Fauci Passes Five-Year Perjury Deadline as DOJ Reportedly Eyes Other Cases

DOJ Indicts Former NIAID Adviser David Morens Over Alleged COVID-19 Records Scheme

Gordon Herbert Discloses COVID-Linked Myocarditis, Reports Recovery Ahead of Canada Job

California Monitors ‘Cicada’ COVID Variant Detected at Low Levels in Wastewater

Hamburg Court Bans Wiesendanger’s Deception Claim Against Drosten

Cicada Covid Subvariant Found in 23 Countries, Not Yet in Brazil

‘Cicada’ COVID Variant Spreads Globally as Officials Track Its Rise

‘Cicada’ COVID Variant Found in 25 U.S. States as WHO Puts BA.3.2 Under Monitoring

‘Cicada’ COVID Variant BA.3.2 Detected in 25 U.S. States as Tracking Intensifies

CDC Tracks BA.3.2 COVID Variant With Heavy Spike Mutations as U.S. Detections Expand

‘India Lockdown’ Searches Jump as Government Rejects Rumors and Flags LPG Strain

Severe COVID and Flu Linked to Higher Long-Term Lung Cancer Risk, Cell Study Finds

St Basil's Aged Care Fined $150,000 Over PPE Training Failures in Deadly 2020 COVID Outbreak

Orlando Man Charged After Shovel Attack at Chinese Restaurant Over Claimed COVID Threat